TBIO(Delisted)
Telesis BioยทNASDAQ
--
--(--)
TBIO fundamentals
Telesis Bio (TBIO) released its earnings on Aug 10, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 10, 2021
EPS
Revenue
Revenue & Expenses
TBIO has released its 2024 Q2 earnings report, with revenue of 1.55M, reflecting a YoY change of -77.87%, and net profit of -12.59M, showing a YoY change of -51.86%. The Sankey diagram below clearly presents TBIO's revenue sources and cost distribution.
Key Indicators
Telesis Bio (TBIO) key financial stats and ratios, covering profitability, financial health, and leverage.
Telesis Bio (TBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Telesis Bio (TBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Telesis Bio (TBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Telesis Bio (TBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Telesis Bio (TBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
